Sorry, you need to enable JavaScript to visit this website.

Michael Binks, M.D.

Vice President, Clinical Research
  • Group: Rare Disease Research Unit
  • Location: Cambridge, MA

I joined Pfizer in 2014 to lead Clinical Research within the Rare Diseases Research Unit. I am currently the research project leader for the DMD gene therapy program.

I qualified in medicine at University College London (UCL), UK before training in internal medicine, gastroenterology, neurology, respiratory and emergency medicine and rheumatology.

I am UK accredited Rheumatologist. My scientific interests have been in immunology and immunopharmacology.

I served as a Lecturer in Immunology and as an Arthritis Research Council and Jules Thorn Clinical Fellow at UCL, conducting research on antigen presentation and dendritic cell biology including the rare diseases Wiskott Aldrich Syndrome and scleroderma.

I joined the pharmaceutical industry in immune-inflammation discovery biology, translational and experimental medicine and clinical pharmacology and have progressed programs from discovery to the clinic to POC.

I am the author of over 40 peer reviewed publications and 1 patent.


  1. Report of a TREAT-NMD/World Duchenne Organisation Meeting on Dystrophin Quantification Methodology
    Journal of Nueromuscular Disease,
    Annemieke Aartsma-Rus J, Pallavi L, Hendrik N, Owens J, Binks M, Marisol M, Rahul Phadke N, Van
    Deutekom J, Morris G, Rao V. A., Hoffman E, Muntoni F, Arechavala-Gomeza V
Media Name: seng_cheng300x170.jpg
Seng H Cheng, Ph.D.

Senior Vice President & Chief Scientific Officer, Rare Disease

Media Name: k_beaverson300x170.jpg
Katherine L Beaverson, M.S.

Executive Director, Patient Advocacy Lead

Media Name: christian_czech300x170.jpg
Christian Czech, PH.D.

Senior Director, Biology and Nice Site Lead

Media Name: grimwood300x170.jpg
Sarah Grimwood, Ph.D.

Executive Director, Head of Portfolio, Strategy & Operations

Media Name: LaRosa_21_300x170.jpg
Greg LaRosa, Ph.D.

Vice President, Head of Scientific Research

Media Name: clark_pan_300x170.jpg
Clark Pan, PH.D.

Vice President, Gene Therapy and Discovery Biology

Ken Rhodes, Ph.D.

Vice President, Rare Neurology and Discovery Biology